Literature DB >> 10805977

Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.

C M Gonzalez1, S M Griffey, D K Naydan, E Flores, R Cepeda, G Cattaneo, B R Madewell.   

Abstract

Eleven dogs with canine transmissible venereal tumour (CTVT) were given vincristine sulphate chemotherapy to induce tumour regression. Biopsy specimens were collected from tumours during the growth phase, before chemotherapy, and again from the same dogs during the regression induced by chemotherapy. Laboratory assessment included cytology, histology, the number of tumour cells in relation to the number of intratumoral leucocytes, proliferative and apoptotic fractions of tumour cells, intratumoral vessel density, and fibrosis. The results revealed that during regression, tumour cell proliferation ceased, apoptosis increased, leucocytes increased (with increased proportion of T lymphocytes), tumour parenchyma collapsed around intratumoral vessels, and fibrosis increased. These results, which were similar to findings in dogs with spontaneous regression of CTVT, suggest that tumour immunity plays a role in tumour regression after modest chemotherapy. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805977     DOI: 10.1053/jcpa.1999.0366

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  8 in total

1.  How far can we go with structural mass spectrometry of protein complexes?

Authors:  Michal Sharon
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-04       Impact factor: 3.109

2.  Canine transmissible venereal tumour: assessment of mast cell numbers as indicators of the growth phase.

Authors:  S Mukaratirwa; T Chiwome; S Chitanga; E Bhebhe
Journal:  Vet Res Commun       Date:  2006-08       Impact factor: 2.459

3.  Canine Parvovirus ns1 gene and Chicken Anemia vp3 gene induce partial oncolysis of Canine Transmissible Venereal Tumor.

Authors:  Aubid Hussain Bhat; Bhaskar Ganguly; Ashok Kumar Tiwari; Arup Kumar Das
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

4.  Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.

Authors:  Halit Kanca; Gizem Tez; Kazim Bal; Dogukan Ozen; Eray Alcigir; Sevil Atalay Vural
Journal:  Vet Med Sci       Date:  2018-08-17

5.  Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor.

Authors:  Dan Frampton; Hagen Schwenzer; Gabriele Marino; Lee M Butcher; Gabriele Pollara; Janos Kriston-Vizi; Cristina Venturini; Rachel Austin; Karina Ferreira de Castro; Robin Ketteler; Benjamin Chain; Richard A Goldstein; Robin A Weiss; Stephan Beck; Ariberto Fassati
Journal:  Cancer Cell       Date:  2018-04-09       Impact factor: 31.743

6.  Detection of progressive and regressive phase and LINE-1 retrotransposon in transfected dogs with transmissible venereal tumor during chemotherapy.

Authors:  Sevil Atalay Vural; Rifki Haziroglu; Mehmet R Vural; Ibrahim M Polat; Arda S Tunc
Journal:  J Vet Sci       Date:  2018-09-30       Impact factor: 1.672

7.  Conventional-Vincristine Sulfate vs. Modified Protocol of Vincristine Sulfate and L-Asparaginase in Canine Transmissible Venereal Tumor.

Authors:  Chanokchon Setthawongsin; Patharakrit Teewasutrakul; Sirikachorn Tangkawattana; Somporn Techangamsuwan; Anudep Rungsipipat
Journal:  Front Vet Sci       Date:  2019-09-18

Review 8.  Testing the theory of immune selection in cancers that break the rules of transplantation.

Authors:  Ariberto Fassati; N Avrion Mitchison
Journal:  Cancer Immunol Immunother       Date:  2009-12-22       Impact factor: 6.968

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.